Advisornet Financial’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-400
Closed -$5.59K 2471
2023
Q1
$5.59K Hold
400
﹤0.01% 1459
2022
Q4
$2.64K Hold
400
﹤0.01% 1607
2022
Q3
$2K Hold
400
﹤0.01% 1695
2022
Q2
$2K Hold
400
﹤0.01% 1722
2022
Q1
$3K Hold
400
﹤0.01% 1742
2021
Q4
$5K Hold
400
﹤0.01% 1665
2021
Q3
$7K Hold
400
﹤0.01% 1556
2021
Q2
$8K Hold
400
﹤0.01% 1475
2021
Q1
$8K Hold
400
﹤0.01% 1425
2020
Q4
$7K Hold
400
﹤0.01% 1374
2020
Q3
$10K Sell
400
-200
-33% -$4.99K ﹤0.01% 1279
2020
Q2
$18K Hold
600
﹤0.01% 1143
2020
Q1
$19K Hold
600
﹤0.01% 1081
2019
Q4
$27K Buy
+600
New +$24.9K ﹤0.01% 1096

Other funds holding RCEL

Advisornet Financial's RCEL Position: Q2 2023 in Review

Advisornet Financial sold out of Avita Medical (RCEL) in Q2 2023, closing a stake of 400 shares — an estimated $5.59K sold.

Advisornet Financial first reported a position in RCEL in Q4 2019 and held it in 14 quarters. The position peaked at $27K in Q4 2019. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2023.

  • Advisornet Financial reported no remaining Avita Medical position as of Q2 2023 after selling out during the quarter.
  • Advisornet Financial sold 400 Avita Medical shares in Q2 2023, an estimated $5.59K.
  • Advisornet Financial first reported a position in Avita Medical in Q4 2019 and held it in 14 quarters.
  • Advisornet Financial's Avita Medical position peaked at $27K in Q4 2019.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2023.

Based on Advisornet Financial's 13F filing for Q2 2023, filed 14 Jul 2023.